Article Excerpt: There are signs that CMS (Center for Medicaid and Medicare Services) may be embracing digital therapeutics soon. In January, CMS finalized a rule called the Medicare Coverage of Innovative Technology (MCIT), which would make technologies with a breakthrough status from the Food and Drug Administration eligible for reimbursement under Medicare for four years… In addition to MCIT, a bill introduced last year may create a stronger pathway to reimbursement for digital therapeutics. The Prescription Digital Therapeutics to Support Recovery Act would ensure Medicare and Medicaid cover prescription digital therapeutics that render behavioral health services, including programs that address mental health disorders and substance abuse. If it is eventually passed, this bill would create a benefit category for digital therapeutics…
Full Article: https://tinyurl.com/u32dx42v
Article Source: Fast Company